Mayordomo, Reyname .
HRN: 20-37-39 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/23/2024
CLINDAMYCIN 300MG (CAP)
06/23/2024
06/29/2024
ORAL
300mg
Q8
Sp Perenial Mass Excission
Waiting Final Action
Indication: Prophylaxis Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes